ITMI922953A1 - Inibitori a doppia attivita' biologica di no sintasi e cicloossigenasi procedimento per la loro preparazione e composizioni terapeutiche che li contengono. - Google Patents

Inibitori a doppia attivita' biologica di no sintasi e cicloossigenasi procedimento per la loro preparazione e composizioni terapeutiche che li contengono.

Info

Publication number
ITMI922953A1
ITMI922953A1 IT002953A ITMI922953A ITMI922953A1 IT MI922953 A1 ITMI922953 A1 IT MI922953A1 IT 002953 A IT002953 A IT 002953A IT MI922953 A ITMI922953 A IT MI922953A IT MI922953 A1 ITMI922953 A1 IT MI922953A1
Authority
IT
Italy
Prior art keywords
synthasis
cyclooxygenes
procedure
contain
preparation
Prior art date
Application number
IT002953A
Other languages
English (en)
Inventor
Serge Auvin
Pierre Braquet
Colette Broquet
De Lassauniere Pierre Etienne Chabrier
Original Assignee
Sod Conseils Rech Applic
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sod Conseils Rech Applic filed Critical Sod Conseils Rech Applic
Publication of ITMI922953A1 publication Critical patent/ITMI922953A1/it
Application granted granted Critical
Publication of IT1256761B publication Critical patent/IT1256761B/it

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C65/00—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C65/01—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing hydroxy or O-metal groups
    • C07C65/03—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing hydroxy or O-metal groups monocyclic and having all hydroxy or O-metal groups bound to the ring
    • C07C65/05—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing hydroxy or O-metal groups monocyclic and having all hydroxy or O-metal groups bound to the ring o-Hydroxy carboxylic acids
    • C07C65/10—Salicylic acid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C211/00—Compounds containing amino groups bound to a carbon skeleton
    • C07C211/01—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms
    • C07C211/02—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
    • C07C211/03—Monoamines
    • C07C211/04—Mono-, di- or tri-methylamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/52—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton
    • C07C229/54—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton with amino and carboxyl groups bound to carbon atoms of the same non-condensed six-membered aromatic ring
    • C07C229/56—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton with amino and carboxyl groups bound to carbon atoms of the same non-condensed six-membered aromatic ring with amino and carboxyl groups bound in ortho-position
    • C07C229/58—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton with amino and carboxyl groups bound to carbon atoms of the same non-condensed six-membered aromatic ring with amino and carboxyl groups bound in ortho-position having the nitrogen atom of at least one of the amino groups further bound to a carbon atom of a six-membered aromatic ring, e.g. N-phenyl-anthranilic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C279/00—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
    • C07C279/04—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to acyclic carbon atoms of a carbon skeleton
    • C07C279/14—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to acyclic carbon atoms of a carbon skeleton being further substituted by carboxyl groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C279/00—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
    • C07C279/30—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to nitro or nitroso groups
    • C07C279/32—N-nitroguanidines
    • C07C279/36—Substituted N-nitroguanidines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C317/00—Sulfones; Sulfoxides
    • C07C317/44—Sulfones; Sulfoxides having sulfone or sulfoxide groups and carboxyl groups bound to the same carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C57/00—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
    • C07C57/30—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/02—Esters of acyclic saturated monocarboxylic acids having the carboxyl group bound to an acyclic carbon atom or to hydrogen
    • C07C69/12—Acetic acid esters
    • C07C69/14—Acetic acid esters of monohydroxylic compounds
    • C07C69/145—Acetic acid esters of monohydroxylic compounds of unsaturated alcohols
    • C07C69/157—Acetic acid esters of monohydroxylic compounds of unsaturated alcohols containing six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D209/26—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with an acyl radical attached to the ring nitrogen atom
    • C07D209/28—1-(4-Chlorobenzoyl)-2-methyl-indolyl-3-acetic acid, substituted in position 5 by an oxygen or nitrogen atom; Esters thereof
ITMI922953A 1992-01-04 1992-12-23 Inibitori a doppia attivita' biologica di no sintasi e cicloossigenasiprocedimento per la loro preparazione e composizioni terapeutiche che li contengono. IT1256761B (it)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB929200114A GB9200114D0 (en) 1992-01-04 1992-01-04 Dual inhibitors of no synthase and cyclooxygenase

Publications (2)

Publication Number Publication Date
ITMI922953A1 true ITMI922953A1 (it) 1994-06-23
IT1256761B IT1256761B (it) 1995-12-15

Family

ID=10708115

Family Applications (1)

Application Number Title Priority Date Filing Date
ITMI922953A IT1256761B (it) 1992-01-04 1992-12-23 Inibitori a doppia attivita' biologica di no sintasi e cicloossigenasiprocedimento per la loro preparazione e composizioni terapeutiche che li contengono.

Country Status (34)

Country Link
US (2) US5480999A (it)
JP (1) JP2984498B2 (it)
KR (1) KR100287539B1 (it)
AT (1) AT401054B (it)
AU (1) AU664399B2 (it)
BE (1) BE1006227A3 (it)
CA (1) CA2085555C (it)
CH (1) CH685629A5 (it)
DE (1) DE4244539B4 (it)
DK (1) DK157592A (it)
DZ (1) DZ1657A1 (it)
ES (1) ES2052452B1 (it)
FI (1) FI925883A (it)
FR (2) FR2685916B1 (it)
GB (2) GB9200114D0 (it)
GR (1) GR1001443B (it)
HK (1) HK22296A (it)
HU (1) HU220218B (it)
IE (1) IE71675B1 (it)
IT (1) IT1256761B (it)
LU (1) LU88208A1 (it)
MA (1) MA22753A1 (it)
MY (1) MY109846A (it)
NL (1) NL194889C (it)
NO (1) NO302943B1 (it)
NZ (1) NZ245499A (it)
OA (1) OA10050A (it)
PL (1) PL169432B1 (it)
PT (1) PT101165B (it)
RU (1) RU2104999C1 (it)
SE (1) SE511568C2 (it)
TN (1) TNSN93001A1 (it)
TW (1) TW267152B (it)
ZA (1) ZA9210080B (it)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU682768B2 (en) * 1994-05-07 1997-10-16 Astra Aktiebolag Bicyclic amidine derivatives as inhibitors of nitric oxide synthetase
DK0758890T3 (da) 1994-05-11 2005-04-18 Jes Olesen Anvendelse af NO indfangere, inhibitorer eller antagonister ved behandling af migræne
CA2132690A1 (en) * 1994-09-22 1996-03-23 Dean Willis Control and modulation of inflammatory response in humans in need of such control and modulation
US6066333A (en) * 1994-09-22 2000-05-23 William Harvey Research Limited Pharmaceutical control of inflammation
FR2727111B1 (fr) * 1994-11-21 1997-01-17 Hoechst Lab Nouveaux analogues soufres d'aminoacides, leur procede de preparation et leurs applications comme medicaments
PT793646E (pt) 1994-11-23 2002-03-28 Biovitrum Ab Carboxilatos de aminoguanidina destinados ao tratamento de diabetes mellitus nao-insulinodependente
JPH08333258A (ja) 1994-12-14 1996-12-17 Japan Tobacco Inc チアジン又はチアゼピン誘導体及びそれら化合物を含有してなる一酸化窒素合成酵素阻害剤
ES2096524B1 (es) * 1994-12-22 1997-11-16 Sanchez Manuel Guerra Uso de la ng-monometil-l-arginina, para aumentar la capacidad de hacer ejercicio fisico.
FR2730930B1 (fr) 1995-02-27 1997-04-04 Oreal Utilisation d'inhibiteurs de no-synthase pour diminuer l'effet irritant cutane de produits utilises dans le domaine cosmetique ou pharmaceutique
GB9504350D0 (en) * 1995-03-04 1995-04-26 Sod Conseils Rech Applic Arginine derivatives
US5703073A (en) * 1995-04-19 1997-12-30 Nitromed, Inc. Compositions and methods to prevent toxicity induced by nonsteroidal antiinflammatory drugs
GB9514518D0 (en) * 1995-07-15 1995-09-13 Sod Conseils Rech Applic Guanidine salt inhibitors of NO synthase and cyclooxygenase
WO1997032575A1 (en) * 1996-03-05 1997-09-12 Children's Hospital Medical Center Mercapto derivatives as inhibitors of cyclooxygenases
JP2000511177A (ja) 1996-05-21 2000-08-29 ファルマシア・アンド・アップジョン・カンパニー インスリン非依存性糖尿病治療のためのアミノグアニジンカルボキシレート ラクタム類
US5872145A (en) * 1996-08-16 1999-02-16 Pozen, Inc. Formulation of 5-HT agonist and NSAID for treatment of migraine
US8022095B2 (en) * 1996-08-16 2011-09-20 Pozen, Inc. Methods of treating headaches using 5-HT agonists in combination with long-acting NSAIDs
US6586458B1 (en) 1996-08-16 2003-07-01 Pozen Inc. Methods of treating headaches using 5-HT agonists in combination with long-acting NSAIDs
US5789395A (en) * 1996-08-30 1998-08-04 The Research Foundation Of State University Of New York Method of using tetracycline compounds for inhibition of endogenous nitric oxide production
IT1288123B1 (it) * 1996-09-04 1998-09-10 Nicox Sa Uso di nitroderivati per l'incontinenza urinaria
US6066092A (en) * 1997-11-06 2000-05-23 Cady; Roger K. Preemptive prophylaxis of migraine device and method
IT1301966B1 (it) 1998-07-30 2000-07-20 Zambon Spa Composizioni farmaceutiche ad attivita' analgesica
US6207700B1 (en) * 1999-01-07 2001-03-27 Vanderbilt University Amide derivatives for antiangiogenic and/or antitumorigenic use
US6737427B2 (en) * 2000-01-31 2004-05-18 Genaera Corporation Mucin synthesis inhibitors
US7345051B2 (en) * 2000-01-31 2008-03-18 Genaera Corporation Mucin synthesis inhibitors
US7163958B2 (en) * 2002-07-03 2007-01-16 Nitromed Inc. Nitrosated nonsteroidal antiinflammatory compounds, compositions and methods of use
CA2493156A1 (en) * 2002-07-29 2004-02-05 Nitromed, Inc. Cyclooxygenase-2 selective inhibitors, compositions and methods of use
JP4616009B2 (ja) * 2002-12-26 2011-01-19 ポーゼン インコーポレイテッド ＮＳＡＩＤｓおよびトリプタンを含有する多層剤型
WO2004110492A2 (en) * 2003-06-06 2004-12-23 Glaxo Group Limited Composition comprising triptans and nsaids
CA2530058A1 (en) * 2003-06-19 2004-12-29 Genaera Corporation Mucin synthesis inhibitors
US20050002859A1 (en) * 2003-06-25 2005-01-06 Vanderbilt University COX-2-targeted imaging agents
EP1744747A4 (en) * 2004-04-26 2009-12-02 Univ Vanderbilt INDIC ACID AND INDULECTIC ACID DERIVATIVES AS THERAPEUTIC ACTIVITIES WITH REDUCED GASTROINTESTINAL TOXICITY
US20080139449A1 (en) * 2005-01-04 2008-06-12 Wolfgang Jahnke X-Ray Structure of Human Fpps and Use For Selecting Fpps Binding Compounds
WO2007149456A2 (en) * 2006-06-19 2007-12-27 Vanderbilt University Methods and compositions for diagnostic and therapeutic targeting of cox-2
WO2013059245A1 (en) 2011-10-17 2013-04-25 Vanderbilt University Indomethacin analogs for the treatment of castrate-resistant prostate cancer
TWM469254U (zh) 2013-08-29 2014-01-01 J D Components Co Ltd 自行車之三件式豎管

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR6838M (it) * 1967-12-08 1969-03-31
ES423794A1 (es) * 1974-03-01 1976-05-01 Medicinales S A Promesa Prod Procediemiento de obtencion de una nueva sal soluble de acido acetilsalicilico.
FR2320759A1 (fr) * 1975-08-11 1977-03-11 Union Pharma Scient Appl Solution d'acide acetylsalicylique extemporanee injectable
IT1127274B (it) * 1979-12-04 1986-05-21 Selvi & C Spa Sali dell'acido 5-fluoro-2-metil-1-(p-(metilsulfinil)-benzilidene)-indene-3-acetico
JPS5781409A (en) * 1980-11-10 1982-05-21 Toko Yakuhin Kogyo Kk External plaster
CA1213888A (en) * 1983-09-28 1986-11-12 Warner-Lambert Company L-arginine isoxicamate
US5081184A (en) * 1985-08-02 1992-01-14 General Electric Company Solvent-resistant, compatible blends of polyphenylene ethers and linear polyesters
JPS6393718A (ja) * 1986-10-07 1988-04-25 Green Cross Corp:The 注射剤
US5028627A (en) * 1989-09-13 1991-07-02 Cornell Research Foundation, Inc. Method of using arginine derivatives to inhibit systemic hypotension associated with nitric oxide production or endothelial derived relaxing factor
US5059712A (en) * 1989-09-13 1991-10-22 Cornell Research Foundation, Inc. Isolating aminoarginine and use to block nitric oxide formation in body
DK0424028T3 (da) * 1989-10-17 1996-01-29 Merck & Co Inc S(+)-ibuprofen-L-aminosyre og S(+)-ibuprofen-D-aminosyre som et forbedret smertestillende middel med fremskyndet indtrædelse
GB8929076D0 (en) * 1989-12-22 1990-02-28 Scras Treatment of shock by blocking agents of edrf effect or formation
US5468476A (en) * 1994-03-16 1995-11-21 Ahluwalia; Gurpreet S. Reduction of hair growth

Also Published As

Publication number Publication date
PL169432B1 (pl) 1996-07-31
FI925883A0 (fi) 1992-12-28
US5360925A (en) 1994-11-01
GB2263111B (en) 1995-08-16
NL9300001A (nl) 1993-08-02
MY109846A (en) 1997-08-30
HU9204173D0 (en) 1993-04-28
DK157592D0 (da) 1992-12-30
CA2085555C (en) 2004-07-20
BE1006227A3 (fr) 1994-06-14
ES2052452A1 (es) 1994-07-01
KR930016389A (ko) 1993-08-26
NO924835L (no) 1993-07-05
GB9227026D0 (en) 1993-02-17
IE922954A1 (en) 1993-07-14
ZA9210080B (en) 1993-08-02
HUT64047A (en) 1993-11-29
IE71675B1 (en) 1997-02-26
JPH05286916A (ja) 1993-11-02
FR2685869B1 (fr) 1995-06-09
MA22753A1 (fr) 1993-07-01
ATA256092A (de) 1995-10-15
US5480999A (en) 1996-01-02
JP2984498B2 (ja) 1999-11-29
ES2052452B1 (es) 1995-02-01
NZ245499A (en) 1995-07-26
TNSN93001A1 (fr) 1994-03-17
GR1001443B (el) 1993-12-30
SE9203825L (sv) 1993-07-05
HU220218B (hu) 2001-11-28
IT1256761B (it) 1995-12-15
LU88208A1 (fr) 1993-04-15
DK157592A (da) 1993-07-05
NL194889C (nl) 2003-06-04
PT101165B (pt) 1999-09-30
FR2685916B1 (fr) 2001-09-28
PL297247A1 (en) 1993-09-06
DE4244539A1 (it) 1993-07-08
OA10050A (fr) 1996-10-14
AT401054B (de) 1996-06-25
SE511568C2 (sv) 1999-10-18
NO302943B1 (no) 1998-05-11
PT101165A (pt) 1994-02-28
SE9203825D0 (sv) 1992-12-18
GB9200114D0 (en) 1992-02-26
DZ1657A1 (fr) 2002-02-17
NL194889B (nl) 2003-02-03
CA2085555A1 (en) 1993-07-05
FR2685869A1 (fr) 1993-07-09
DE4244539B4 (de) 2006-10-26
GB2263111A (en) 1993-07-14
FI925883A (fi) 1993-07-05
AU3049892A (en) 1993-07-08
TW267152B (it) 1996-01-01
AU664399B2 (en) 1995-11-16
CH685629A5 (fr) 1995-08-31
NO924835D0 (no) 1992-12-14
HK22296A (en) 1996-02-16
FR2685916A1 (fr) 1993-07-09
RU2104999C1 (ru) 1998-02-20
KR100287539B1 (ko) 2001-04-16

Similar Documents

Publication Publication Date Title
ITMI922953A1 (it) Inibitori a doppia attivita' biologica di no sintasi e cicloossigenasi procedimento per la loro preparazione e composizioni terapeutiche che li contengono.
AU8138687A (en) Agents for combating pests and plant treatment agents
EP0440809A4 (en) Methylenediphosphonic acid compound and anti-inflammatory containing the same as active ingredient
IT8748403A0 (it) Composizione di fluoruro a lento rilascio per il trattamento e la prevenzione di affezioni ossee
IT8648097A0 (it) Preparazione e composizioni farma3n-alchilammidi della d(+)ceutiche e cosmetiche che le contencarnitina dotate di attivita' antigono batterica,procedimento per la loro
IT1241631B (it) "n,n'-ditrimetossibenzoilpiperazine 2-sostituite, procedimento per la loro preparazione e composizioni terapeutiche che le contengono
HUT51105A (en) Pesticide comprising substituted acrylic acid ester derivatives as active ingredient and process for producing the active ingredients
ITMI922742A0 (it) Composti ad attivita' terapeutica utili per il trattamento di malattieconnesse ad una carenza di glutatione, procedimento per la loro preparazione e composizioni farmaceutiche che li contengono.
IT1240349B (it) Solfonil-derivati di tieno-triazolo-diazepine,un procedimento per la loro preparazione e composizioni terapeutiche che li contengono
IT8423896A0 (it) Diacilderivati della glicerilfosforilcolina ad attivita' terapeutica, procedimento per laloro preparazione e relative composizioni farmaceutiche.
ZA935647B (en) Treatment of sickle cell disease
ITMI922950A0 (it) Oligosaccaridi aventi attivita' biologica e procedimento per la loro preparazione di glicosaminoglicani
ITMI932193A0 (it) Composti ad attivita' antiistaminica per la loro preparazione e composizioni farmaceutiche che li contengono
FR2604707B1 (fr) Procede de preparation d'un compose therapeutique actif
IT1199821B (it) 2-cloro-12-(-3-dimetilammino-2-metilpropil)-12h-dibenzo-/d,g//1,3,6/d iossazocine otticamente attive e procedimento per la loro preparazione
ITMI931371A1 (it) Procedimento per la preparazione dell'erdosteina
IT9021609A0 (it) Impianto per la produzione di calzature e procedimento per l'impiego di detto impianto
IT8520514A0 (it) Composizioni di farmaci dotate di attivita' antimicrobica eprocedimento per la loro preparazione.
IT1185525B (it) Derivait di amminodiarilsolfossidi,procedimento per la loro preparazione e composizioni farmaceutiche e pesticide che li contengono
HU895940D0 (en) Ointment prepared from active agents of medical plants
IT1200470B (it) Composti ad attivita' antibatterica,loro preparazione e composizioni farmaceutiche relative
IT8822858A0 (it) Composizioni per la riduzione di flebectasie e procedimento per la loro preparazione
IT1243702B (it) Composti ad attivita' nootropa, procedimento per la loro preparazione e relative composizioni farmaceutiche
AU6936894A (en) Blood vessel thickening inhibitor and smooth muscle fiber migration inhibitor each containing 7-thiaprostaglandin e1 compound as active ingredient
IT1233861B (it) Composizione di composti che migliorano l'attivita' analgesica, antipiretica e antiinfiammatoria

Legal Events

Date Code Title Description
0001 Granted
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19961227